Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy

CONTEXT: Toxicity-monitoring plays an important role in all cancer treatment, however, early recognition is vital for detecting and treating immune-related symptoms. Preparing a Patient Reported Outcomes tool and including melanoma patients receiving immunotherapy in the reporting of symptoms, may o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolstrup, Lærke K., Bastholt, Lars, Zwisler, Ann-Dorthe, Dieperink, Karin B., Pappot, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515745/
https://www.ncbi.nlm.nih.gov/pubmed/30900035
http://dx.doi.org/10.1186/s41687-019-0111-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515745/
https://www.ncbi.nlm.nih.gov/pubmed/30900035
http://dx.doi.org/10.1186/s41687-019-0111-8

Ejemplares similares